Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes - Archive ouverte HAL Access content directly
Journal Articles Journal of Allergy and Clinical Immunology Year : 2017

Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes

(1) , (2) , , , (3) , (4) , (5) , (6, 7)
1
2
3
4
5
6
7

Abstract

The outcome of bullous pemphigoid (BP), the most frequent autoimmune skin-blistering disease, involves matrix metalloproteinase 9 (MMP-9), IL-17, and IL-23 release from infiltrated inflammatory cells. The chemokine CXCL10 has been associated with several autoimmune diseases, but its participation in BP pathophysiology still needs to be clarified.

Dates and versions

hal-01754072 , version 1 (30-03-2018)

Identifiers

Cite

Meriem Riani, Sébastien Le Jan, Julie Plée, Anne Durlach, Richard Le Naour, et al.. Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes. Journal of Allergy and Clinical Immunology, 2017, 139 (3), pp.863 - 872.e3. ⟨10.1016/j.jaci.2016.08.012⟩. ⟨hal-01754072⟩
79 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More